Results 271 to 280 of about 16,658,609 (280)

CAR T cell therapy for multiple myeloma

Nature Cancer, 2023
openaire   +2 more sources

Updates on CAR T‐cell therapy in B‐cell malignancies

Immunological Reviews, 2019
Nirali Shāh, Elad Jacoby
exaly  

Immunotherapy-related cognitive impairment after CAR T cell therapy in mice

Cell
Michelle Monje, Pamelyn J Woo, Lehi Acosta-Alvarez   +2 more
exaly  

Frontiers in CAR-T cell therapy for autoimmune diseases

Trends in Pharmacological Sciences
Yan-Ruide Li, Zibai Lyu
exaly  

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

New England Journal of Medicine
Adolfo Aleman, Oliver Van Oekelen, David T. Melnekoff, Leah Grossman, Tarek H. Mouhieddine, Agata Kurowski, Ivan Odak, Sidorela Reci, Shriya Desai, Shannon Meledathu, Malini P. Naidu, Ravi P. Shukla, Rudra P. Dutta, Katerina Kappes, Kseniya Serebryakova, Hayley Jackson, Jordan Lu, Anastasia Chatikhine, Raksha Kulkarni, Zahra Moinfar, Matthew M. Croken, Meenakshi Mehrotra, Brett Baskovich, Sampanna Rayamajhi, Shambavi Richard, Adriana C. Rossi, Christian Salib, Jane Houldsworth, Brian D. Brown, Miriam Merad, Alessandro Laganà, Patrick M. Brunner, Sundar Jagannath, Joshua D. Brody, Samir Parekh   +34 more
openaire   +2 more sources

FDA-approved CAR T-cell Therapy: A Decade of Progress and Challenges

Current Pharmaceutical Biotechnology
Sharina Hamzah, Renukha Sellappans
exaly  

Medicare to Cover CAR T-Cell Therapies

JAMA, 2019
openaire   +2 more sources

CAR T-Cell Therapy in Autoimmune Disease

New England Journal of Medicine
Wolfgang, Merkt, Hanns-Martin, Lorenz, Michael, Schmitt   +2 more
openaire   +4 more sources

Emerging trends in clinical allogeneic CAR cell therapy

Med
Yan-Ruide Li, Zibai Lyu, Yichen Zhu
exaly  

Hypereosinophilia after CAR T-cell therapy

Leukemia & Lymphoma
Bérenger Poirier, Roch Houot, Samuel Vic, Mickael Roussel, Catherine Henry, Cédric Pastoret, Ondine Messéant   +6 more
openaire   +2 more sources